Pri-miR526b and Pri-miR655 Are Potential Blood Biomarkers for Breast Cancer

SIMPLE SUMMARY: Previously, we reported that the expression of two oncogenic miRNAs, miR526b and miR655, in poorly metastatic breast cancer cells enhances aggressive breast cancer phenotypes. Furthermore, miR526b and miR655 expression in breast tumors is associated with poor patient survival. We rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Majumder, Mousumi, Ugwuagbo, Kingsley Chukwunonso, Maiti, Sujit, Lala, Peeyush K, Brackstone, Muriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345356/
https://www.ncbi.nlm.nih.gov/pubmed/34359739
http://dx.doi.org/10.3390/cancers13153838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345356/
https://www.ncbi.nlm.nih.gov/pubmed/34359739
http://dx.doi.org/10.3390/cancers13153838

Ejemplares similares